Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

NViroMune Founder and Long Covid Expert Dr. Norman B. Gaylis Supports Initiatives on International Long Covid Awareness Day


News provided by

NViroMune

Mar 15, 2023, 08:35 ET

Share this article

Share toX

Share this article

Share toX

Dr. Gaylis is on the forefront of groundbreaking research after treating more than 2,000 Long Covid patients and publishing an eye-opening study in a peer-reviewed journal

MIAMI, March 15, 2023 /PRNewswire/ -- Norman B. Gaylis MD, MACR, FACP, an eminent physician, researcher, and published author, is aligning with the Long Covid Community on March 15 for International Long Covid Awareness Day. This first yearly observance seeks to boost awareness of the impacts of more than 65 million estimated people suffering with Long Covid throughout the world. After treating more than 2,000 Long Covid patients at his clinic in Aventura, Florida, Dr. Gaylis says he is pleased to see events such as International Long Covid Awareness Day because Long Covid patients have been overlooked in Covid discussions, studies, and statistics until recently.

Continue Reading
Dr. Norman B. Gaylis is a board-certified Rheumatologist, internist, and COVID expert who has been elected by his peers to the prestigious title of Master of Rheumatology (MACR). He has lectured, taught, and presented at medical schools and conferences throughout the world. More recently, and after treating more than 2,000 COVID patients, he is dedicated to researching and developing treatments for COVID long hauler patients.
Dr. Norman B. Gaylis is a board-certified Rheumatologist, internist, and COVID expert who has been elected by his peers to the prestigious title of Master of Rheumatology (MACR). He has lectured, taught, and presented at medical schools and conferences throughout the world. More recently, and after treating more than 2,000 COVID patients, he is dedicated to researching and developing treatments for COVID long hauler patients.
Dr. Norman B. Gaylis examines a patient at his Arthritis and Rheumatic Disease Specialties Clinic in Aventura, Florida. He is regarded as a Covid and Long Covid expert for groundbreaking research and studies that are changing the way patients are treated.
Dr. Norman B. Gaylis examines a patient at his Arthritis and Rheumatic Disease Specialties Clinic in Aventura, Florida. He is regarded as a Covid and Long Covid expert for groundbreaking research and studies that are changing the way patients are treated.

"Fortunately, Long Covid patients have finally garnered the attention of the healthcare community, government organizations, and even economists who are predicting Long Covid is the next health crisis that will cost more than $37 trillion to address," said Gaylis. "We need to continue to educate the public with events such as International Long Covid Awareness Day to help with support groups, advocacy, and resources Long Covid patients so desperately need."

On March 15, social media platforms will flood feeds with special online events, including black and white images of Long Covid sufferers sharing what they can no longer do as a result of the illness. The hashtags #LongCovid and #LongCovidAwarenessDay will be used to help find and spark conversations. Since Long COVID is often a debilitating illness with a complicated list of more than 200 lingering symptoms, Gaylis believes it is important for sufferers to share information to help demystify the disease. Treating his own patients prompted him to embark on Long Covid research and a groundbreaking study.

"After treating so many patients, I became extremely interested in finding ways to alleviate symptoms, so I collaborated with like-minded researchers at Tel Aviv University on a one-arm open labeled study. We analyzed symptom of patients in 18 states with histories of lingering effects of the virus three to 11 months after infection," he explained.

Results revealed that on average, Long Covid symptoms were reported as significantly milder after two weeks of adding nothing to the participants' regimens other than the studied nutraceuticals. Dramatic improvements were observed after four weeks, and no adverse effects were reported. More importantly, each symptom was notably alleviated in 72-84% of all study participants.

The data collected was published in the peer-reviewed journal, Frontiers in Nutrition. In addition, Dr. Gaylis researched and documented the role of the autonomic nervous system in Long Covid patients, presenting data titled "Autonomic Nervous System Dysfunction: Common Among Patients With Long COVID, an Exploratory Evaluation," at the annual American College of Rheumatologists Conference last November in Philadelphia. His findings have been called game-changing in regard to shedding light on how COVID long hauler patients are treated.

Based on extensive research and nutraceuticals formulated for the study, Gaylis founded the supplements company NViroMune and collaborated with scientists on a proprietary, patented formula that specifically addresses Long Covid symptoms. RESTORE is an innovative combination of GRAS-approved (Generally Regarded As Safe) nutrients and plant bio-extracts for critical immune restoration after surviving a viral infection. Ingredients include Zinc, Vitamin D, Quercetin, Bromelain, St. John's Wort, Indian Frankincense, and Beta Caryophyllene, a Cannabinoid CB 2 Agonist.

"Long Covid has destroyed the lives of many people who have lost jobs, homes, relationships and their overall quality of life," added Gaylis. "To date, there is no decisive protocol to for treating Long Covid, so we are excited to offer RESTORE, a supplement that has been statistically proven to help significantly reduce and alleviate the symptoms of Long Covid."

Gaylis added "We support the International Long Covid Awareness Day campaign not only on March 15, but every day as we continue to be on the front lines with Long Covid patients who need resources and support from the healthcare community."

For more information about the study or to interview Dr. Norman B. Gaylis, contact Rhonda Price at (561) 371-9407.

ABOUT DR. NORMAN B. GAYLIS

Dr. Norman B. Gaylis is a board-certified Rheumatologist and internist who has been elected by his peers to the prestigious title of Master of Rheumatology (MACR). He has been in clinical practice and research for the past 40 years and his work has been appeared in more than 50 publications. He has lectured, taught, and presented at medical schools and conferences throughout the world. More recently, and after treating many COVID patients, he is dedicated to researching and developing treatments for COVID long hauler patients.

Contact: Rhonda Price

(561) 371-9407

[email protected] 

SOURCE NViroMune

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.